Showing results (1141-1150 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|June 14, 2015
Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major DepressionR Davis, M I WildeCNS Drugs|August 7, 2021
Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood DisordersFelicia Ceban, Joshua D Rosenblat, Kevin Kratiuk, et al.CNS Drugs|May 16, 2021
Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral SclerosisColin J Mahoney, Rebekah M Ahmed, William Huynh, et al.CNS Drugs|May 7, 2021
Erythropoietin Improves Poor Outcomes in Preterm Infants with Intraventricular HemorrhageJuan Song, Yong Wang, Falin Xu, et al.CNS Drugs|April 28, 2021
Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-AnalysisDee Lin, Philippe Thompson-Leduc, Isabelle Ghelerter, et al.CNS Drugs|June 25, 2015
Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to DateLawrence K Fung, Antonio Y HardanCNS Drugs|May 8, 2015
Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical UseNoble George, Emily G Gean, Ayon Nandi, et al.CNS Drugs|June 7, 2020
Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical ImplicationsEmilio Perucca, Meir BialerCNS Drugs|September 3, 2021
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.CNS Drugs|June 22, 2020
Methadone for Pain Management: A Pharmacotherapeutic ReviewDenise Kreutzwiser, Qutaiba A TawficPageof 211